Jon Filderman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNE DESIGN CORP | Director/Board Member | 2019-04-01 | - |
| Corporate Secretary | 2019-04-01 | - | |
| PROMETHEUS BIOSCIENCES, INC. | Director/Board Member | 2023-06-15 | - |
Career history of Jon Filderman
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 2 |
| Corporate Secretary | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
- Stock Market
- Insiders
- Jon Filderman
- Experience
